Cancer Research: Proposed breast cancer screening would increase deaths ♦ Toxic mushroom-based drug for colorectal cancer ♦ Personalized pancreas cancer clinical trial

Proposed breast cancer screening guidelines would increase deaths, experts say The breast cancer screening guidelines proposed yesterday by the United States Preventive Services Task Force would result in thousands of additional and unnecessary breast cancer deaths each year, according to radiologists at Loyola University Health System

Higher-than-expected pediatric cancer rates identified in two Florida areas Higher than expected rates of pediatric cancers have been identified in the Miami metro area and an area west of the Everglades. Comparisons across analyses reveal characteristics of the detected patterns, including the number of cases , types of cancer, racial composition and timing of the cluster west of the Everglades

How to conduct a personalized pancreas cancer clinical trial Leaders of an ongoing pancreatic cancer clinical trial known as the Individualized Molecular Pancreatic Cancer Therapy or 'IMPaCT' trial, have been learning ways to bring about about a new paradigm of personalized cancer care for pancreatic cancer and other aggressive cancer types.

Immune therapy tested in study of women with triple-negative breast cancer Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer, a persistently difficult form of the disease to treat.

Toxic mushroom-based drug may help battle colorectal cancer For some time, cancer scientists have considered the toxin, alpha-amanitin derived from “death cap” mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.